Mutations, Drugs Drive Cancer by Blurring Growth Signals
Genetic mutations in a form of non–small cell lung cancer may drive tumor formation by blurring cells’ perception of key growth signals, according to a new laboratory study published Aug. 31, 2018, in Science.